Verition Fund Management LLC Igm Biosciences, Inc. Transaction History

Verition Fund Management LLC

  • $17.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$6.51 - $11.47 $170,041 - $299,596
26,120 New
26,120 $179,000
Q2 2023

Aug 14, 2023
BUY
$8.86 - $14.0 $153,331 - $242,284
17,306 New
17,306 $159,000
Q2 2021

Aug 16, 2021
SELL
$57.98 - $96.6 $226,237 - $376,933
-3,902 Closed
0 $0
Q1 2021

May 18, 2021
BUY
$71.56 - $121.23 $279,227 - $473,039
3,902 New
3,902 $299,000

Others Institutions Holding IGMS

# of Institutions
81
Shares Held
20.7M
Call Options Held
68K
Put Options Held
52.2K
View Full List

About IGM Biosciences, Inc.

IGMS Quotes by TradingView
  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $200M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email